Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora
- Autores:
-
Gálvez, Kenny Mauricio
Solano, María Helena
Ramírez, Carlos Alberto
Abello, Virginia
Pedraza, Enrique
Esguerra, Hermann
Rosales, Carmen
Reyes, Jesús Antonio
Villamizar Gómez, Francy Licet
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2007
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- spa
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2367
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2367
https://doi.org/10.31260/RepertMedCir.v16.n3.2007.470
- Palabra clave:
- aplasia médula ósea
trasplante alogénico
terapia inmunosupresora
supervivencia
factores pronósticos
aplasia bone marrow
allogeneic transplant
immunosuppressive therapy
survival
prognostic factors
- Rights
- openAccess
- License
- Fundación Universitaria de Ciencias de la Salud FUCS - 0
| id |
FUCS2_a8d3561db420841f67a59c1541ce61e7 |
|---|---|
| oai_identifier_str |
oai:repositorio.fucsalud.edu.co:001/2367 |
| network_acronym_str |
FUCS2 |
| network_name_str |
Repositorio Digital Institucional ReDi |
| repository_id_str |
|
| dc.title.spa.fl_str_mv |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| dc.title.translated.eng.fl_str_mv |
Primary therapy in bone marrow aplasia: Allogeneic transplant of hematopoietic progenitors vs. immunosuppressive therapy |
| title |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| spellingShingle |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora aplasia médula ósea trasplante alogénico terapia inmunosupresora supervivencia factores pronósticos aplasia bone marrow allogeneic transplant immunosuppressive therapy survival prognostic factors |
| title_short |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| title_full |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| title_fullStr |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| title_full_unstemmed |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| title_sort |
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora |
| dc.creator.fl_str_mv |
Gálvez, Kenny Mauricio Solano, María Helena Ramírez, Carlos Alberto Abello, Virginia Pedraza, Enrique Esguerra, Hermann Rosales, Carmen Reyes, Jesús Antonio Villamizar Gómez, Francy Licet |
| dc.contributor.author.spa.fl_str_mv |
Gálvez, Kenny Mauricio Solano, María Helena Ramírez, Carlos Alberto Abello, Virginia Pedraza, Enrique Esguerra, Hermann Rosales, Carmen Reyes, Jesús Antonio |
| dc.contributor.author.none.fl_str_mv |
Villamizar Gómez, Francy Licet |
| dc.subject.spa.fl_str_mv |
aplasia médula ósea trasplante alogénico terapia inmunosupresora supervivencia factores pronósticos |
| topic |
aplasia médula ósea trasplante alogénico terapia inmunosupresora supervivencia factores pronósticos aplasia bone marrow allogeneic transplant immunosuppressive therapy survival prognostic factors |
| dc.subject.eng.fl_str_mv |
aplasia bone marrow allogeneic transplant immunosuppressive therapy survival prognostic factors |
| publishDate |
2007 |
| dc.date.accessioned.none.fl_str_mv |
2007-09-01 00:00:00 2022-02-21T20:36:47Z |
| dc.date.issued.none.fl_str_mv |
2007-09-01 |
| dc.date.available.none.fl_str_mv |
2007-09-01 00:00:00 2022-02-21T20:36:47Z |
| dc.type.spa.fl_str_mv |
Artículo de revista |
| dc.type.eng.fl_str_mv |
Journal article |
| dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
| dc.type.coar.spa.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
| dc.type.driver.spa.fl_str_mv |
info:eu-repo/semantics/article |
| dc.type.version.spa.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.content.spa.fl_str_mv |
Text |
| dc.type.coarversion.spa.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| format |
http://purl.org/coar/resource_type/c_6501 |
| status_str |
publishedVersion |
| dc.identifier.doi.none.fl_str_mv |
10.31260/RepertMedCir.v16.n3.2007.470 |
| dc.identifier.issn.none.fl_str_mv |
0121-7372 |
| dc.identifier.uri.none.fl_str_mv |
https://repositorio.fucsalud.edu.co/handle/001/2367 |
| dc.identifier.eissn.none.fl_str_mv |
2462-991X |
| dc.identifier.url.none.fl_str_mv |
https://doi.org/10.31260/RepertMedCir.v16.n3.2007.470 |
| identifier_str_mv |
10.31260/RepertMedCir.v16.n3.2007.470 0121-7372 2462-991X |
| url |
https://repositorio.fucsalud.edu.co/handle/001/2367 https://doi.org/10.31260/RepertMedCir.v16.n3.2007.470 |
| dc.language.iso.spa.fl_str_mv |
spa |
| language |
spa |
| dc.relation.references.spa.fl_str_mv |
1- British Committee for Standards in Haematology (BCSH) General Haematology Task Force. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003;123:782-801. 2- Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976 Jul;48(1):63-70. 3- Young NS. Aplastic anaemia. Lancet. 1995 Jul 22;346(8969):228-32. 4- Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, Locasciulli A, Van Lint MT, Tichelli A, McCann S, Marsh J, Ljungman P, Hows J, Marin P, Schrezenmeier H. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.Semin Hematol. 2000 Jan;37(1):69-80. 5- Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood. 2000 Mar 15;95(6):1931-4. 6- Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000 Jan;37(1):56-68. 7- Horowitz MM. Current status of allogenic bone marrow transplantation in acquired aplastic anemia. Semin hematol 2000; 37:30-42. 8- Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood. 1986 Jul;68(1):119-25. 9- Storb R, Leisenring W, Deeg HJ, Anasetti C, Appelbaum F, Bensinger W, Buckner CD, Clift R, Doney K, Hansen J, et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia. Blood. 1994 May 1;83(9):2749-50. 10- Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974; 18:295-304. 11- Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991 Jul;28(3):250-9. 12- Kaplan EL, Meler P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81. 13- Gluckman E, Rokicka-Milewska R, Hann I, Nikiforakis E, Tavakoli F, Cohen-Scali S, Bacigalupo A; European Group for Blood and Marrow Transplantation Working Party for Severe Aplastic Anemia. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol. 2002 Dec;119(4):1075-82. 14- Viollier R, Passweg J, Gregor M, Favre G, Kuhne T, Nissen C, Gratwohl A, Tichelli A. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.Ann Hematol. 2005 Jan;84(1):47-55. 15- Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988 Oct;70(2):177-82. 16- Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995 Jan 1;85(1):283-90. 17- Schrezenmeier H, Bredeson C, Bruno B, Loberiza FR, Camitta B, Oneto R, et al. Comparison of allogeneic bone marrow and peripheral blood stem cell transplantation for aplastic anaemia: collaborative study of European Blood and Marrow Transplant Group (EBMT) and International Bone Marrow Transplant Registry (IBMTR). Blood 2003- 267. 18- Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, GordonSmith EC, Marmont AM, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992 Jan 1;79(1):269-75. 19- Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant. 2006 Apr;37(7):641-9. 20- Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, Sakamaki H, Ikuta K, Tsuchida M, Hoshi Y, Morishima Y, Kodera Y. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002 Aug 1;100(3):799-803. 21- Mao P, Zhu Z, Wang H, Wang S, Mo W, Ying Y, Li Q, Xu Y. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol. 2005 Nov;75(5):430-5. 22- Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, Ribaud P, Devergie A, Traineau R, Gluckman E, Socié G. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004 Apr 1;103(7):2490-7. |
| dc.relation.bitstream.none.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/470/514 |
| dc.relation.citationedition.spa.fl_str_mv |
Núm. 3 , Año 2007 : Julio – Septiembre |
| dc.relation.citationendpage.none.fl_str_mv |
150 |
| dc.relation.citationissue.spa.fl_str_mv |
3 |
| dc.relation.citationstartpage.none.fl_str_mv |
143 |
| dc.relation.citationvolume.spa.fl_str_mv |
16 |
| dc.relation.ispartofjournal.spa.fl_str_mv |
Revista Repertorio de Medicina y Cirugía |
| dc.rights.spa.fl_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 |
| dc.rights.accessrights.spa.fl_str_mv |
info:eu-repo/semantics/openAccess |
| dc.rights.uri.spa.fl_str_mv |
https://creativecommons.org/licenses/by-nc-sa/4.0/ |
| dc.rights.coar.spa.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
| rights_invalid_str_mv |
Fundación Universitaria de Ciencias de la Salud FUCS - 0 https://creativecommons.org/licenses/by-nc-sa/4.0/ http://purl.org/coar/access_right/c_abf2 |
| eu_rights_str_mv |
openAccess |
| dc.format.mimetype.spa.fl_str_mv |
application/pdf |
| dc.publisher.spa.fl_str_mv |
Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud |
| dc.source.spa.fl_str_mv |
https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/470 |
| institution |
Fundación Universitaria de Ciencias de la Salud - FUCS |
| bitstream.url.fl_str_mv |
https://repositorio.fucsalud.edu.co/bitstreams/5748c399-a623-42b2-954f-e56f7787bab9/download |
| bitstream.checksum.fl_str_mv |
49ae905a13e78b134b1e7ad769714768 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 |
| repository.name.fl_str_mv |
Repositorio Digital de la Fundación Universitaria de Ciencias de la Salud |
| repository.mail.fl_str_mv |
redi@fucsalud.edu.co |
| _version_ |
1828220177891721216 |
| spelling |
Gálvez, Kenny Mauriciobc5e4202e197472d875ce38a4c7fe4f0300Solano, María Helenacfbd69f8e4d28c6e6c3d2a032972d1fc500Ramírez, Carlos Albertobb341c2e7dae2572e9d990d748dbef9c300Abello, Virginia662248ee15853429c95b78d6ce692008500Pedraza, Enriqueca8f118621415440f02bbc869b2ffdd8300Esguerra, Hermanna0bb9a748b3529bb6d40daa52ede226c300Rosales, Carmen4ae86eac9a63e3df0cfd62d3fb2f24c3500Reyes, Jesús Antonio0f2c18d89424285a1ec23c0ca8ea8979300Villamizar Gómez, Francy Licetvirtual::39-12007-09-01 00:00:002022-02-21T20:36:47Z2007-09-012007-09-01 00:00:002022-02-21T20:36:47ZSociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la SaludFundación Universitaria de Ciencias de la Salud FUCS - 0info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/http://purl.org/coar/access_right/c_abf2https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/470aplasia médula óseatrasplante alogénicoterapia inmunosupresorasupervivenciafactores pronósticosaplasia bone marrowallogeneic transplantimmunosuppressive therapysurvivalprognostic factorsTerapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresoraPrimary therapy in bone marrow aplasia: Allogeneic transplant of hematopoietic progenitors vs. immunosuppressive therapyapplication/pdfArtículo de revistaJournal articlehttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionTexthttp://purl.org/coar/version/c_970fb48d4fbd8a8510.31260/RepertMedCir.v16.n3.2007.4700121-7372https://repositorio.fucsalud.edu.co/handle/001/23672462-991Xhttps://doi.org/10.31260/RepertMedCir.v16.n3.2007.470spa1- British Committee for Standards in Haematology (BCSH) General Haematology Task Force. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003;123:782-801.2- Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP, Rappeport JM, Storb R. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976 Jul;48(1):63-70.3- Young NS. Aplastic anaemia. Lancet. 1995 Jul 22;346(8969):228-32.4- Bacigalupo A, Brand R, Oneto R, Bruno B, Socie G, Passweg J, Locasciulli A, Van Lint MT, Tichelli A, McCann S, Marsh J, Ljungman P, Hows J, Marin P, Schrezenmeier H. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience.Semin Hematol. 2000 Jan;37(1):69-80.5- Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, Gabbas A, Dufour C, Arcese W, Testi G, Broccia G, Carotenuto M, Coser P, Barbui T, Leoni P, Ferster A. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood. 2000 Mar 15;95(6):1931-4.6- Frickhofen N, Rosenfeld SJ. Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Semin Hematol. 2000 Jan;37(1):56-68.7- Horowitz MM. Current status of allogenic bone marrow transplantation in acquired aplastic anemia. Semin hematol 2000; 37:30-42.8- Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood. 1986 Jul;68(1):119-25.9- Storb R, Leisenring W, Deeg HJ, Anasetti C, Appelbaum F, Bensinger W, Buckner CD, Clift R, Doney K, Hansen J, et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia. Blood. 1994 May 1;83(9):2749-50.10- Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation. 1974; 18:295-304.11- Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S, Erickson K, Flowers M, Hansen J, Loughran T, et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol. 1991 Jul;28(3):250-9.12- Kaplan EL, Meler P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.13- Gluckman E, Rokicka-Milewska R, Hann I, Nikiforakis E, Tavakoli F, Cohen-Scali S, Bacigalupo A; European Group for Blood and Marrow Transplantation Working Party for Severe Aplastic Anemia. Results and follow-up of a phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anaemia. Br J Haematol. 2002 Dec;119(4):1075-82.14- Viollier R, Passweg J, Gregor M, Favre G, Kuhne T, Nissen C, Gratwohl A, Tichelli A. Quality-adjusted survival analysis shows differences in outcome after immunosuppression or bone marrow transplantation in aplastic anemia.Ann Hematol. 2005 Jan;84(1):47-55.15- Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S, et al. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol. 1988 Oct;70(2):177-82.16- Paquette RL, Tebyani N, Frane M, Ireland P, Ho WG, Champlin RE, Nimer SD. Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: comparison with bone marrow transplantation. Blood. 1995 Jan 1;85(1):283-90.17- Schrezenmeier H, Bredeson C, Bruno B, Loberiza FR, Camitta B, Oneto R, et al. Comparison of allogeneic bone marrow and peripheral blood stem cell transplantation for aplastic anaemia: collaborative study of European Blood and Marrow Transplant Group (EBMT) and International Bone Marrow Transplant Registry (IBMTR). Blood 2003- 267.18- Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, GordonSmith EC, Marmont AM, et al. Bone marrow transplantation for severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992 Jan 1;79(1):269-75.19- Passweg JR, Pérez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W, Hows JM, Marsh JC, Pasquini R, Schrezenmeier H, Socié G, Zhang MJ, Bredeson C. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant. 2006 Apr;37(7):641-9.20- Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A, Sakamaki H, Ikuta K, Tsuchida M, Hoshi Y, Morishima Y, Kodera Y. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002 Aug 1;100(3):799-803.21- Mao P, Zhu Z, Wang H, Wang S, Mo W, Ying Y, Li Q, Xu Y. Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia. Eur J Haematol. 2005 Nov;75(5):430-5.22- Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, Ribaud P, Devergie A, Traineau R, Gluckman E, Socié G. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004 Apr 1;103(7):2490-7.https://revistas.fucsalud.edu.co/index.php/repertorio/article/download/470/514Núm. 3 , Año 2007 : Julio – Septiembre150314316Revista Repertorio de Medicina y CirugíaPublication89867781-8b73-4edb-adc3-85bacc6d7d3dvirtual::39-189867781-8b73-4edb-adc3-85bacc6d7d3dvirtual::39-10000-0002-1875-114Xvirtual::39-1https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=0000498319virtual::39-1OREORE.xmltext/xml2632https://repositorio.fucsalud.edu.co/bitstreams/5748c399-a623-42b2-954f-e56f7787bab9/download49ae905a13e78b134b1e7ad769714768MD51001/2367oai:repositorio.fucsalud.edu.co:001/23672024-06-14 10:54:25.562https://creativecommons.org/licenses/by-nc-sa/4.0/Fundación Universitaria de Ciencias de la Salud FUCS - 0metadata.onlyhttps://repositorio.fucsalud.edu.coRepositorio Digital de la Fundación Universitaria de Ciencias de la Saludredi@fucsalud.edu.co |